The Food Supplements eCommerce market in Denmark is predicted to reach US$37.3m revenue by 2025, reflecting an estimated growth rate of 5% compared to 2024.

Access Europe Dietary Supplements Industry Overview which includes Europe country analysis of (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe), market split by Ingredient, Form, Applications, End User, Type, Distribution Channel

In 2023, overseas shipments of medicaments containing vitamins and provitamins increased by 7.3% to 423 tons for the first time since 2020, thus ending a two-year declining trend.

Snapshot img

Vitamin B3 Market Size 2024-2028

The vitamin B3 market size is forecast to increase by USD 84.8 million at a CAGR of 4.49% between 2023 and 2028.

The market is experiencing significant growth due to several key trends and factors. The increasing awareness of health and wellness, particularly In the US and North America, has led to a rise in consumer spending on vitamin supplements, including those derived from brown rice, a rich source of niacin or vitamin B3. In the animal feed industry, vitamin B3 is widely used as a feed additive to improve the growth and health of livestock, such as beef and poultry. In the food industry, vitamin B3 is used in various applications, including In the production of bread and meat processing, to enhance the nutritional value and shelf life of these products. 
Niacin is naturally present in various foods, such as tuna, salmon, vegetables, and other nutrient-rich sources. Moreover, the demand for vitamin B3 in cosmeceuticals and personal care products is also on the rise, as it is known to improve skin health and mental health. Avocado, mushroom, and salmon are among the natural food sources of vitamin B3, making them popular ingredients in various health and wellness products. Regulatory control on supplement usage limits, particularly In the US, is another factor driving the growth of the market. Overall, the market is expected to continue its growth trajectory due to these trends and factors.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market encompasses various forms of Niacin and Nicotinic Acid, essential pyridine carboxylic acids that play a crucial role in human and animal nutrition. Niacin, also known as Vitamin B3, is an organic compound integral to energy production and DNA repair. In human nutrition, it alleviates deficiency symptoms like nausea, anemia, headaches, tiredness, and improves cardiovascular health. In animal nutrition, it enhances growth and improves feed efficiency. Niacin is extensively used in pharmaceutical-grade supplements, available as powders, granular, and liquids. It is also employed as a feed additive for livestock and poultry. In the food industry, niacin is added to processed foods, including fortified packaged foods, to enhance nutritional value.
Niacin and its amide form, Niacinamide, are also integral to cosmeceuticals due to their skin-enhancing properties. However, the increasing prevalence of high blood cholesterol and deficiency symptoms necessitates the growing demand for niacin supplements. Overall, the market is expected to witness steady growth, driven by its diverse applications in human and animal nutrition and the cosmetics industry.

How is this Industry segmented and which is the largest segment?

The industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Type

  Food grade
  Pharmaceutical grade


Geography

  North America

    Canada
    US


  Europe

    Denmark


  Asia

    China
    India


  Rest of World (ROW)

By Type Insights

The food grade segment is estimated to witness significant growth during the forecast period.

Vitamin B3, also known as niacin or nicotinic acid, is an essential organic compound in human and animal nutrition. It plays a crucial role in reducing high blood cholesterol levels and heart-related issues. Foods rich in vitamin B3 include red meat, poultry, fish such as tuna and salmon, brown rice, fortified cereals, and bread. Consumers prefer natural sources over supplements due to potential toxicity concerns. Vitamin B3 deficiency can lead to anemia, headaches, tiredness, and nausea. In the healthcare and animal nutrition segments, vitamin B3 is used In the form of niacin supplements, nicotinic acid, powder, granular, and liquid. The demand for vitamin B3 is increasing due to health consciousness, disease resistance, and changing consumer lifestyles.

Get a glance at the Vitamin B3 Industry report of share of various segments Request Free Sample

The food grade segment was valued at USD 200.50 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 38% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The market is experiencing growth due to increasing consumer awareness of its health benefits. Vitamin B3, also known as niacin or nicotinic acid, is an organic compound essential for human and animal nutrition. It is found naturally in foods such as tuna, salmon, vegetable

According to the research of Future Market Insights, over the projected period, the Glucosamine Supplements Market is expected to expand at a CAGR of 4.8%. The industry's estimated value will increase from US$ 583.6 Million in 2023 to US$ 932.7 Million in 2033. The Glucosamine Supplements Market was worth US$ 567.2 Million at the end of 2022.

Attributes	Details
Market Size Value in 2023	US$ 583.6 Million
Market Forecast Value in 2033	US$ 932.7 Million
Global Growth Rate (2023 to 2033)	4.8%
Forecast Period	2023 to 2033
Global Market Share of USA, Germany, Japan, and Australia	69.7%

Glucosamine Supplements Market Report Scope

Attribute	Details
Forecast Period	2023 to 2033
Historical Data Available for	2018 to 2022
Market Analysis	USD Million for Value and Units for Volume
Key Regions Covered	North America; Latin America; Europe; Asia Pacific; MEA
Key Countries Covered	Philippines, India, Malaysia, Thailand, USA, Germany, China, Japan, Denmark, Canada, Mexico, Poland, UK, Turkey, France, Italy, Spain, South Korea, Russia, Australia, Brazil, Argentina, South Africa
Key Segments Covered	Type, Product Type, Application, Region
Key Companies Profiled	GlaxoSmithKline; Pfizer Inc.; Merck & Co. Inc.; Sanofi; Novartis AG; Solgar; BioTech USA; Nature's Best; Mylan N.V.; Teva Pharmaceutical Industries Ltd.
Report Coverage	DROT Analysis, Market Forecast, Company Share Analysis, Market Dynamics and Challenges, Competitive Landscape and Strategic Growth Initiatives
Customization & Pricing	Available upon Request

The industry is an integral part of the pharmaceutical supply chain and the pharmaceutical sector's research and development process, with some of the largest pharma manufacturing companies across the globe being based in Europe. Over the five years through 2024, industry revenue is expected to fall at a compound annual rate of 1% to reach €613 billion, including a fall of 1.5% in 2024. Overall, an ageing population across Europe is widening the available market for manufacturers, with the rising healthcare expenditure of most EU countries supporting the industry. The COVID-19 outbreak skyrocketed the industry’s importance to the functioning of the European economy, with many manufacturers rushing to develop and patent COVID-19 vaccines and other related tests. Spiking hospital admissions during the height of the pandemic heightened demand for various pharmaceutical products. Although EU pharma manufacturers are investing heavily in new treatment research and development, boosting industry growth, they are also facing intense competition from overseas suppliers, particularly from China and India, when it comes to selling intensive-care medical products. Industry revenue is expected to grow at a compound annual rate of 4.9% over the five years through 2029 to reach €779.9 billion. The EU reform of the pharmaceuticals framework will address systemic shortages and ensure the security of the supply of critical medicinal products, boosting industry performance. The rising adoption of big data and new manufacturing practices will speed up the commercialisation of different medical treatments, supporting industry performance.

Production of Medicaments Containing Vitamins in Denmark - 2025. Find the latest marketing data on the IndexBox platform.

The Danish vitamin market contracted to $59M in 2024, dropping by -11.4% against the previous year. Overall, consumption showed a noticeable contraction. Vitamin consumption peaked at $143M in 2013; however, from 2014 to 2024, consumption remained at a lower figure.